David Kaplan

Die Suchergebnisse bei Legimi sind auf die vom Nutzer angegebenen Suchkriterien zugeschnitten. Wir versuchen Titel, die für unsere Nutzer von besonderem Interesse sein könnten, durch die Bezeichnung "Bestseller" oder "Neuheit" hervorzuheben. Titel in der Liste der Suchergebnisse können auch sortiert werden - die Sortierauswahl hat Vorrang vor anderen Ergebnissen."

Dr. David Kaplan graduated with A.B, Ph.D., and M.D. degrees from the University of Chicago.  He was a pathology resident at Barnes and Jewish Hospitals and a postdoctoral fellow at Washington University.  Since 1984 he served as a faculty member at Case Western Reserve University and an attending physician at University Hospitals Cleveland.  In 2016 he founded a biotechnology company based on his invention of a powerful technology that enhanced the sensitivity of flow cytometric analysis.  Dr. Kaplan has made many advancements throughout his scientific career including the first cloning of human influenza-specific cytotoxic T cells, the first gene transfer into human T cells, the first use of antisense transfection to inhibit expression of a protein to probe its function in the context of the human T cell, and the first demonstration of intercellular immunoregulation via cell surface receptors.